Nearly 590 million people worldwide live with diabetes, and the majority are of working age — yet a sweeping global survey reveals that workplaces have remained largely indifferent to their presence. Insulet Corporation, maker of the Omnipod insulin management system, has translated this indifference into data, finding that nearly four in five workers with diabetes encounter bias, while employers struggle to name even basic symptoms of the condition. With the launch of a campaign timed to Diabetes Awareness Month, the company is asking a quiet but consequential question: what does it cost a pe
Insulet Survey Reveals Widespread Workplace Bias Against Diabetes, Launches Inclusion Campaign
Diabetes may not be visible, but it shapes everything
So Insulet commissioned this survey. Are they doing this because they care about workplace inclusion, or because it's good marketing for their insulin pump?
Both things can be true. The survey itself is real—nearly 10,000 workers across 11 countries, conducted by Censuswide, which follows market research standards. The findings are stark: 79 percent of people with diabetes report bias at work. That's not a number Insulet invented to make a point.
But let's be clear about what we're looking at. Insulet is a publicly traded company selling insulin delivery devices. A campaign that raises awareness about workplace barriers to diabetes management could absolutely increase demand for their products. That doesn't make the survey false, but it's worth naming the incentive structure.
Fair. And the survey does show real pain points. Twenty-one percent of people with diabetes hide their condition from colleagues. Forty-two percent experience anxiety tied to managing it at work. Those are human costs, not marketing angles.
What about the solutions? The survey says mindfulness tools help, and that private spaces and food options matter. Are those things Insulet can actually influence?
Insulet can't force employers to change their policies. What they're doing is providing resources—whitepapers, checklists, personal stories—to make the case to employers that these changes are worth making. They're also donating to organizations focused on workplace inclusion for people with diabetes.
The question is whether resources and donations move the needle. The survey shows 86 percent of people with diabetes experience barriers at work. That's a massive number. A whitepaper and some checklists might raise awareness, but structural change—actually building private spaces, changing break policies, expanding cafeteria options—that requires employer buy-in and budget allocation.
So what's the realistic outcome here?
Insulet is positioning itself as a leader on this issue. They're saying they'll sustain this effort through 2026 and beyond. Whether that translates to actual workplace change depends on whether employers see the business case for inclusion, or whether they see it as a compliance issue, or whether they ignore it entirely.
And we won't know that for a while. This campaign launches in November. The real test is whether, a year from now, we see measurable changes in how workplaces accommodate people with diabetes, or whether this becomes a well-intentioned awareness campaign that doesn't shift behavior.
Der Puls
- A global survey of nearly 10,000 workers across 11 countries exposes a workplace culture where 79% of people with diabetes face bias, and one in five hides their condition entirely to avoid judgment.
- The knowledge gap among colleagues is stark — 61% cannot identify type 1 diabetes symptoms, yet many can readily name fictional characters or sports teams, revealing a troubling hierarchy of what workplaces choose to learn.
- Daily friction compounds the medical burden: more than half of workers with diabetes struggle with inadequate private spaces, limited food options, or insufficient breaks — concrete obstacles with concrete solutions employers have yet to implement.
- Insulet's 'The Day Diabetes Showed Up to Work' campaign deploys whitepapers, personal narratives, employer checklists, and charitable partnerships to convert awareness into structural change.
- The company has signaled this effort extends beyond November, committing to sustained advocacy through 2026 — though whether employers will move from acknowledgment to action remains the open and urgent question.
Nearly 590 million people worldwide live with diabetes, and the majority are of working age — yet a sweeping global survey reveals that workplaces have remained largely indifferent to their presence. Insulet Corporation, maker of the Omnipod insulin management system, has translated this indifference into data, finding that nearly four in five workers with diabetes encounter bias, while employers struggle to name even basic symptoms of the condition. With the launch of a campaign timed to Diabetes Awareness Month, the company is asking a quiet but consequential question: what does it cost a person to manage a chronic illness in a workplace that has never truly made room for them?
Nearly 590 million people worldwide live with diabetes, and roughly seven in ten are of working age. Yet for many, arriving at the office means navigating not just a chronic illness but a workplace culture shaped by misunderstanding and indifference. To measure the scope of this problem, Insulet Corporation commissioned a global survey of nearly 10,000 workers across 11 countries and more than ten industry sectors. What emerged was a portrait of systemic bias.
Seventy-nine percent of workers with diabetes reported experiencing bias or misunderstanding on the job. Four in ten described workplace-related anxiety tied to managing their condition. One in five conceals their diagnosis from colleagues or supervisors entirely — a quiet calculation between disclosure and invisibility, neither option comfortable.
The gap between perceived and actual understanding among colleagues is telling. While 57 percent of workers without diabetes feel confident they could support a diabetic colleague, 61 percent cannot identify the symptoms of type 1 diabetes. Canadian communications professional Judy Mitri, who manages her condition with an Omnipod device, put it simply: diabetes may be invisible, but it shapes mental, physical, and emotional well-being. A little empathy, she said, goes a long way.
The practical barriers are equally concrete. Eighty-six percent of workers with diabetes face obstacles at work, with more than half struggling with at least one of three specific problems: no private space to manage their condition, limited food options, or insufficient breaks. These are not abstract grievances — they are the daily friction of managing a chronic illness in an environment not designed with that reality in mind.
To coincide with Diabetes Awareness Month beginning November 1, Insulet is launching a campaign called 'The Day Diabetes Showed Up to Work,' releasing whitepapers, personal narratives from Omnipod users, employer checklists, and charitable initiatives in partnership with the American Diabetes Association, the International Diabetes Federation, and Breakthrough T1D. The company has committed to continuing this work through 2026 and beyond. Whether employers will translate awareness into the structural accommodations the data clearly calls for remains the defining question.
Nearly 590 million people worldwide live with diabetes, and roughly seven in ten are of working age. Yet when they arrive at their offices, many find themselves navigating not just the medical demands of their condition but a workplace culture shaped by misunderstanding, fear of disclosure, and indifference to their needs. Insulet Corporation, the medical device company behind the Omnipod insulin pump system, commissioned a global survey of nearly 10,000 workers across 11 countries to measure the scope of this problem. What emerged was a portrait of systemic workplace bias that extends far beyond individual awkwardness.
The survey, conducted between mid-September and late September 2025 across more than ten industry sectors in countries including the United States, United Kingdom, Canada, Australia, Germany, Spain, Sweden, Denmark, the Netherlands, France, and Saudi Arabia, found that 79 percent of workers with diabetes have experienced bias or misunderstanding at their jobs. Four in ten reported workplace-related anxiety tied to managing their condition. One in five conceals their diabetes from colleagues or supervisors entirely. The numbers suggest a workplace environment where people with diabetes are forced to choose between disclosure and invisibility, neither option comfortable.
The gap between what colleagues without diabetes think they know and what they actually understand is striking. While 57 percent of workers without diabetes say they feel confident supporting colleagues with the condition, 61 percent cannot confidently identify the symptoms of type 1 diabetes. Yet nearly half can name Harry Potter characters or their country's top football teams. The survey captures something beyond mere ignorance: it documents a hierarchy of what workplaces choose to know. One respondent, Judy Mitri, a communications professional in Canada who uses an Omnipod device, framed the issue plainly: diabetes may not be visible, but it shapes mental health, physical health, and emotional well-being. A little empathy, she said, goes a long way.
The practical barriers are equally concrete. Eighty-six percent of workers with diabetes experience obstacles at work because of their condition. More than half struggle with at least one of three specific problems: inadequate private spaces for managing their condition, limited food options, or insufficient breaks. These are not abstract complaints. They are the daily friction that makes work harder for people already managing a chronic illness. Employers, the survey suggests, have clear opportunities to remove these obstacles. Offering private spaces, expanding food choices, and granting adequate breaks would address barriers for the majority of workers facing them.
Insulет is launching a campaign called "The Day Diabetes Showed Up to Work" to coincide with Diabetes Awareness Month, which begins November 1. The company is releasing a suite of resources: a whitepaper on healthcare provider support, an infographic summarizing survey findings, personal narratives from Omnipod users and employees living with diabetes, and practical checklists for supporting colleagues. The campaign also includes charitable donations through Insulet's corporate giving program to the American Diabetes Association and the International Diabetes Federation, employee letter-writing initiatives for children newly diagnosed with type 1 diabetes in partnership with Breakthrough T1D, and sponsorships of community events throughout November.
The survey also found that mindfulness tools show measurable impact, with respondents reporting reduced stress, better sleep, and less anxiety when such resources are available. Ashley McEvoy, Insulet's president and chief executive officer, framed the campaign as an effort to "spark action in the workplace" that allows people with diabetes to focus on their work and their lives. The company has signaled this is not a one-month initiative. Insulet says it will continue driving awareness, support, and inclusion throughout 2026 and beyond. What remains to be seen is whether employers will move beyond awareness to the structural changes—the private spaces, the flexible breaks, the food options, the mindfulness programs—that the survey data suggests would actually change the experience of work for the millions of people managing diabetes while trying to do their jobs.
Bemerkenswerte Zitate
Diabetes may not be a visible chronic illness, but it affects many spheres of our lives, whether it's in terms of our mental or physical health, or even our emotions. A little empathy can go a long way.— Judy Mitri, communications professional and Omnipod user in Canada
Nearly 590 million people worldwide live with diabetes, and approximately 70 percent are of working age. Yet too often their experience at work is shaped by misunderstanding, fear of disclosure, and a lack of meaningful support.— Ashley McEvoy, Insulet President and Chief Executive Officer